CCL’s Andre M. Mura filed an amicus brief in support of the plaintiffs/appellees in Wyeth Pharmaceuticals, Inc. v. Daniel, Nos. 63 & 64 EAP 2011, now pending before the Pennsylvania Supreme Court. The brief, filed on behalf of the Pennsylvania Association for Justice, argues that the Federal Drug Administration’s oversight of drug safety is no warrant for barring state-law remedies awarded to punish and deter a drug manufacturer’s reckless disregard for patient safety.